Validating healthcare AI

The Decision Threshold: The Quiet Choice That Turns a Model Score Into an Action

A clinical model rarely hands you an action. It hands you a number, a probability between zero and one, and someone must decide how high it climbs before anything happens. That line is the decision threshold. Move it down and the model flags more people, catching more true cases but also more false alarms.

A clinical model rarely hands you an action. It hands you a number, a probability between zero and one, and someone must decide how high it climbs before anything happens. That line is the decision threshold. Move it down and the model flags more people, catching more true cases but also more false alarms. Move it up and it flags fewer, missing some real cases to spare the healthy from unnecessary follow-up. Nothing about the mathematics tells you where the line belongs, because the answer depends on what each mistake costs and how common the condition is where you work. This is general education, not medical advice, and any decision about your own care belongs with your clinician.

I have watched this choice get treated as a technical afterthought, a default that ships with the software. It is not. With EASY Diabetes, the clinical decision-support system I co-developed and helped run through EASY-1, a registered randomized controlled trial (NCT03258268), the score was the easy part. The argument that mattered was about the cutoff, and it was never really about statistics.

What a threshold actually does

A probability is continuous. A decision is not. At some point a smooth 0 to 1 scale has to collapse into a binary call, act or wait, refer or reassure, and the threshold is the pivot where that collapse happens. Set it at 0.5 and you are flagging any case the model rates more likely than a coin flip. There is nothing sacred about that number. It is a habit, not a law.

Think of the score as sorting everyone along a line from least to most likely. The threshold is a gate dropped somewhere on that line, with everyone to its right called positive and everyone to its left called negative. The model's job was to place people in a sensible order. Where you drop the gate is a separate decision, and it is yours.

Sensitivity and specificity move in opposite directions

Every threshold buys one kind of correctness by spending another. Lower the gate and you catch more of the people who truly have the condition, which raises sensitivity, but you also sweep in more healthy people who happen to score high, which lowers specificity. Raise the gate and the trade reverses. You cannot maximize both at once, and any promise that you can misunderstands what a threshold is.

A concrete picture helps. Suppose the model gives people with the disease higher scores on average than people without it, but the two groups overlap, as they always do in real medicine. Wherever you place the gate inside that overlap, some sick people and some healthy people land on the wrong side. Sliding the gate only chooses which of those two errors you make more of. The overlap is fixed by how good the model is; the threshold just decides how you want to lose.

A single accuracy figure hides this. Two teams using the identical model can report very different sensitivity and specificity simply because they placed the gate in different spots.

The right cutoff depends on the cost of each error

The two errors are not symmetric, and pretending they are is where most trouble starts. A false negative and a false positive rarely carry the same weight, so the threshold should reflect their real costs rather than split the difference by reflex.

Consider a screen for a serious condition that is highly treatable when caught and dangerous when missed. Here a false negative is a person sent home with a disease you could have addressed, and a false positive is a person sent for a confirmatory test that turns out clear. Those are not equal harms. You would rather tolerate extra confirmatory tests than miss the disease, so you lower the gate and buy sensitivity with specificity.

Now flip it. Suppose a positive result triggers an invasive procedure that carries its own real risk, and the condition is not immediately dangerous if watched. A false positive now means someone undergoes a procedure they did not need, so the calculus argues for a higher gate and more caution before you act. Same model, opposite threshold, because the downstream action changed. The number never told you which world you were in. Only clinical judgment does.

Prevalence quietly rewrites everything

There is a second force, and it is the one people forget. How common the condition is in your setting changes what a positive flag is worth, even if the threshold and the model stay the same.

The reason is arithmetic. When a disease is rare, the pool of healthy people is enormous, so even a small false-positive rate produces a flood of false alarms that can swamp the true cases. A model that looked precise in a referral center, where the disease was common, can generate mostly false positives in a general population where it is rare. The threshold did not move. The world underneath it did. A cutoff validated in one setting cannot simply be copied into another and trusted, which is why prevalence belongs in the conversation next to cost.

This is no modeling flaw. It is how rare events behave, and the honest response is to set the operating point for the population in front of you, not the one the model met during development.

Why the threshold is a value judgment, not a default

Put the pieces together and the conclusion is uncomfortable for anyone who wanted a clean technical answer. The model can rank. It cannot tell you how much a missed case hurts compared with a false alarm, nor how rare the condition is on your particular ward. Those two inputs fix the threshold, and both come from outside the mathematics, from clinicians and patients and an honest accounting of consequences.

A threshold that ships as a default has quietly answered those questions for you, using whatever assumptions and population its makers had in mind. That may fit your setting. It may not. Regulated frameworks such as the FDA or EU MDR pathways offer a reasonable backstop, and this is educational rather than legal guidance, but even a cleared tool leaves the operating point as a local choice.

Keep the mental model short. The score is a measurement. The threshold is a decision. Ask two questions before you trust a cutoff: which error would you rather make here, and how common is the condition among the people you see. If nobody in the room can answer those, the threshold has not been chosen. It has only been inherited.

References and sources

  1. Decision curve analysis, a method for evaluating prediction models (Vickers, Med Decis Making 2006)
  2. Measures of diagnostic accuracy: sensitivity, specificity, predictive values, prevalence (Simundic, EJIFCC 2009)
  3. Step-by-step guide to interpreting decision curve analysis and threshold probability (Vickers, Diagn Progn Res 2019)

How this was researched. This explainer is built from the primary sources listed above and reflects Dr. Tojjar's own critical appraisal of that evidence. It explains and evaluates research and does not provide medical care.

This article is for general education and is not medical or professional advice. For guidance about your own health, talk with a qualified clinician.

Cite this article

Tojjar, D. (2025). The Decision Threshold: The Quiet Choice That Turns a Model Score Into an Action. Dr. Damon Tojjar. https://readingtheevidence.org/articles/what-a-decision-threshold-does-in-a-clinical-model/

Back to all insights